Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Comment by Montrose2on Feb 21, 2010 2:05pm
331 Views
Post# 16804361

RE: RE: RE: RE: Reverse Split

RE: RE: RE: RE: Reverse SplitI don't see 100 to 1 reverse as being very likely.  Taking the stock to 27.00 is just going from one extreme to the other.

A 10 to 1 split would see a current price of 2.70 which is above the 2.00 threshold that many, many fund holders utilize.

The issue really becomes whether or not the company goes "back to the well".  If they start raising capital by further share sales then the dreaded dilution spectre surfaces and once again we could see serious decline.  If however they are able to show profitablility annnnnnnnnd sustainability then there would be potential for appreciation no matter what level the share price is or how many shares are outstanding.

I continue to personally believe that once Covidien gets a firm view of how marketable Pennsaid is they will be looking to take the company over.  I see it being essentially "held" at the current levels so that any takeover bid could be in the .50's or .60's which could be presented as a substantial percentage premium on the current price.  That type of action would not be well received by some of our long, long term participants but would allow perhaps the majority to depart with a reasonable albeit diminished profit on the exercise.

Onward and Upward
Bullboard Posts